SELLAS Life Sciences Group (SLS)
NASDAQ:SLS
US Market

SELLAS Life Sciences Group (SLS) Income Statement

Compare
969 Followers

SELLAS Life Sciences Group Income Statement

Last quarter (Q4 2024), SELLAS Life Sciences Group's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, SELLAS Life Sciences Group's net income was $-6.74M. See SELLAS Life Sciences Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 1.00M$ 7.60M$ 1.90M
Gross Profit
$ 0.00$ 0.00$ 900.00K$ 7.40M$ 1.90M
Operating Expenses
$ 31.51M$ 37.87M$ 42.85M$ 32.69M$ 18.88M
Depreciation and Amortization
$ 0.00$ 37.87M$ 457.00K$ 1.27M$ 377.00K
EBITDA
$ -31.51M$ 529.00K$ -31.95M$ -19.66M$ -16.40M
Operating Income
$ -31.51M$ -37.87M$ -41.95M$ -25.29M$ -16.98M
Other Income/Expenses
$ 632.00K$ 529.00K$ 649.00K$ 4.36M$ 208.00K
Pretax Income
$ -30.88M$ -37.34M$ -41.30M$ -20.94M$ -16.77M
Net Income
$ -30.88M$ -37.34M$ -40.65M$ -20.70M$ -16.76M
Per Share Metrics
Basic EPS
$ -0.05$ -0.15$ -0.23$ -0.15$ -0.23
Diluted EPS
$ -0.05$ -0.15$ -0.23$ -0.15$ -0.23
Weighted Average Shares Outstanding
612.02M 249.99M 174.56M 139.33M 71.79M
Weighted Average Shares Outstanding (Diluted)
612.02M 249.99M 174.56M 139.33M 71.79M
Currency in USD

SELLAS Life Sciences Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis